Delve Health

Delve Health

Literature Review | Investigator & Site Qualification.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
N/A

€0.0

round
investor

€0.0

round
N/A

€0.0

round
*

N/A

Grant
Total Funding000k
Notes (0)
More about Delve Health
Made with AI
Edit

Delve Health operates at the intersection of healthcare and technology, providing a digital platform focused on optimizing clinical trials. Founded in 2015 by Wessam Sonbol and Tamer Swidan, who both possess over two decades of experience in the healthcare and tech sectors, the Minneapolis-based company aims to make clinical research more efficient and accessible.

The company's core offering is a comprehensive, end-to-end platform called Clinical StudyPal, which facilitates decentralized, virtual, and hybrid clinical trials. This system is designed to reduce the costs and timelines associated with drug and medical device development. It achieves this by bringing trials directly to patients' homes, which enables more accurate and continuous data collection through the integration of wearables, digital health apps, sensors, and patient-reported outcomes (ePRO). The platform supports a bring-your-own-device (BYOD) model or can provide fully-configured devices to trial participants, enhancing patient engagement and retention.

Delve Health serves a client base that includes pharmaceutical companies, medical device manufacturers, biotechnology firms, and clinical research organizations (CROs). Its business model centers on providing its integrated platform to these organizations, helping them manage trials, ensure regulatory compliance (including HIPAA, GDPR, and 21CFRpart11), and collect high-quality, real-time data. The platform integrates features like electronic consent (eConsent), AI-powered patient pre-screening, and automated engagement tools to improve the trial experience for both sponsors and participants. By shifting tasks from clinical sites to the digital platform, it also helps reduce the operational burden on research staff. To date, the company has supported over 100 studies and 26 registries. Delve Health has secured $1.25 million in funding over two rounds to support its growth and platform development.

Keywords: decentralized clinical trials, hybrid clinical trials, virtual research organization, ePRO, eConsent, patient data collection, clinical trial management, real-world evidence, digital biomarkers, medical device trials, pharmaceutical trials, CRO services, patient engagement platform, wearable integration, digital health platform, clinical research technology, patient retention, remote patient monitoring, clinical data management, life sciences technology

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo